We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

206 hedge funds and large institutions have $5.22B invested in Legend Biotech in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more call options, than puts

Call options by funds: $58.4M | Put options by funds: $19.4M

60% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 58

26% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 27

3% more funds holding

Funds holding: 200 → 206 (+6)

0.22% more ownership

Funds ownership: 26.05% → 26.27% (+0.22%)

10% less capital invested

Capital invested by funds: $5.78B → $5.22B (-$559M)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
34
Increased
93
Reduced
58
Closed
27
Calls
$58.4M
Puts
$19.4M
Net Calls
+$39M
Net Calls Change
+$40.4M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$70.6M
2
Morgan Stanley
Morgan Stanley
New York
+$62.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$61M
4
BlackRock
BlackRock
New York
+$40.9M
5
Millennium Management
Millennium Management
New York
+$35.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$197M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$69.3M
3
NIP
Nicholas Investment Partners
California
-$35.9M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.8M
5
HA
HHLR Advisors
Cayman Islands
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
151
US Bancorp
Minnesota
$394K -$130K -2,057 -24%
Neuberger Berman Group
152
Neuberger Berman Group
New York
$376K +$396K +6,244 New
HCA
153
Harbor Capital Advisors
Illinois
$363K -$60.1K -948 -14%
Daiwa Securities Group
154
Daiwa Securities Group
Japan
$351K +$353K +5,571 +2,134%
Nomura Asset Management
155
Nomura Asset Management
Japan
$343K – – –
NIM
156
NEOS Investment Management
Connecticut
$324K +$341K +5,385 New
VEA
157
Virtus ETF Advisers
New York
$320K +$57.4K +905 +21%
OMC
158
Old Mission Capital
Illinois
$311K +$18.9K +298 +6%
ProShare Advisors
159
ProShare Advisors
Maryland
$306K -$7.48K -118 -2%
PCMH
160
Polymer Capital Management (HK)
Hong Kong
$301K +$317K +5,000 New
CSS
161
Cubist Systematic Strategies
Connecticut
$298K +$53.9K +850 +21%
VPIM
162
Vanguard Personalized Indexing Management
California
$294K +$16K +253 +5%
EAMA
163
EFG Asset Management (Americas)
Florida
$279K -$98.1K -1,548 -25%
Capstone Investment Advisors
164
Capstone Investment Advisors
New York
$277K -$169K -2,663 -37%
CPIG
165
Chicago Partners Investment Group
Illinois
$253K -$45.5K -718 -15%
CI Investments Inc
166
CI Investments Inc
Ontario, Canada
$223K -$31.1K -490 -12%
Lord, Abbett & Co
167
Lord, Abbett & Co
New Jersey
$204K -$3.65M -57,526 -94%
SAM
168
Sectoral Asset Management
Quebec, Canada
$181K -$233K -3,670 -55%
Group One Trading
169
Group One Trading
Illinois
$154K +$162K +2,560 New
AAM
170
Advisors Asset Management
Colorado
$150K +$7.86K +124 +5%
ETC
171
Exchange Traded Concepts
Oklahoma
$127K -$82.7K -1,305 -38%
N
172
Natixis
France
$122K -$6.72K -106 -5%
BCM
173
Barometer Capital Management
Ontario, Canada
$120K +$127K +2,000 New
TRCT
174
Tower Research Capital (TRC)
New York
$115K +$103K +1,624 +576%
BNP Paribas Financial Markets
175
BNP Paribas Financial Markets
France
$105K +$111K +1,752 New
5 6
7
8 9

LEGN Hedge Fund Activity: Q4 2023 in Review

206 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2023, worth a combined $5.22B — down 9.7% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new LEGN positions and 27 closed out — a net gain of 7 holders — while 93 added to existing stakes and 58 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $197M.

  • 206 institutional investors held Legend Biotech (LEGN) as of Q4 2023, up from 200 in Q3 2023.
  • Funds reported $5.22B of Legend Biotech stock for Q4 2023, down 9.7% quarter-over-quarter.
  • 34 funds opened new Legend Biotech positions in Q4 2023 and 27 closed out, a net change of +7 holders.
  • The largest Legend Biotech buyer in Q4 2023 was T. Rowe Price Associates, an estimated $70.6M added.
  • The largest Legend Biotech seller in Q4 2023 was Fidelity Investments, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2023.